Rivas, M.; Pichel, M.; Zylberman, V.; Colonna, M.; Valerio, M.; Massa, C.; Pardo, R.; Ciocchini, A.E.; Sanguineti, S.; Roubicek, I.;
et al. INM004: Polyclonal Neutralizing Antibodies Against Shiga Toxin as a Treatment for Hemolytic Uremic Syndrome. Toxins 2025, 17, 282.
https://doi.org/10.3390/toxins17060282
AMA Style
Rivas M, Pichel M, Zylberman V, Colonna M, Valerio M, Massa C, Pardo R, Ciocchini AE, Sanguineti S, Roubicek I,
et al. INM004: Polyclonal Neutralizing Antibodies Against Shiga Toxin as a Treatment for Hemolytic Uremic Syndrome. Toxins. 2025; 17(6):282.
https://doi.org/10.3390/toxins17060282
Chicago/Turabian Style
Rivas, Marta, Mariana Pichel, Vanesa Zylberman, Mariana Colonna, Marina Valerio, Carolina Massa, Romina Pardo, Andrés E. Ciocchini, Santiago Sanguineti, Ian Roubicek,
and et al. 2025. "INM004: Polyclonal Neutralizing Antibodies Against Shiga Toxin as a Treatment for Hemolytic Uremic Syndrome" Toxins 17, no. 6: 282.
https://doi.org/10.3390/toxins17060282
APA Style
Rivas, M., Pichel, M., Zylberman, V., Colonna, M., Valerio, M., Massa, C., Pardo, R., Ciocchini, A. E., Sanguineti, S., Roubicek, I., Spatz, L., & Goldbaum, F. A.
(2025). INM004: Polyclonal Neutralizing Antibodies Against Shiga Toxin as a Treatment for Hemolytic Uremic Syndrome. Toxins, 17(6), 282.
https://doi.org/10.3390/toxins17060282
